Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nimbus Discovery brings in $24mm in Series A funding

Executive Summary

On the heels of a seed equity top-off four months ago, computational drug discovery start-up Nimbus Discovery LLC has now closed a $24mm Series A financing co-led by returning backer Atlas Venture and new investors SR One and Lilly Ventures. Existing investor Bill Gates (of Microsoft) also participated. Partners from SR One and Lilly Ventures joined the board.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies